Background. The epidemiology of penile human papillomavirus (HPV) infection is not well understood. Our objective was to determine the prevalence of penile HPV infection in the United States.
and Prevention (CDC) to monitor the health and nutritional status of the US population. It samples the civilian, noninstitutionalized US population using a stratified multistage probability sample design. Consenting participants undergo physical examination in a mobile examination center followed by a household interview. Hispanic individuals, African Americans, low-income individuals, and individuals aged ≥60 years are oversampled to allow sufficient sizes for subgroup analysis. The NCHS uses a multilevel weighting system to account for survey design and nonresponse. Adjusting for NHANES survey weights allows the study to provide nationally representative population estimates for the United States.
HPV DNA Collection
The penile swab samples were self-collected by the participants, who were instructed to swab the penile shaft and the outside of the foreskin so that the entire surface of the penis was touched by the swab, including the area under the foreskin for men who were uncircumcised. Of all participants, 1975 men aged 18-59 years submitted their penile swab samples, 218 of which were inadequate or missing for HPV testing. All collected samples were placed into the collection vial with 1 mL of specimen transport media (STM) by trained NHANES personnel. The samples were then sent to the CDC laboratory, where STM samples were kept at 4°C for up to 4 weeks until DNA extraction.
HPV Genotyping
A Roche Linear Array HPV Genotyping test was used to detect HPV types (6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45 , 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, and 89). This test is based on HPV L1 consensus polymerase chain reaction with biotinylated PGM09/11 primer sets and β-globin primers. Samples that were negative for HPV and the β-globin control were considered inadequate for interpretation.
Demographics and Behavioral Data
Demographic characteristics including age, sex, marital status, race/ethnicity, education level, and family poverty level were collected during the household interviews. We estimated poverty index according to the US Census Bureau definition by dividing total family income by the poverty threshold after adjusting for family size. We also determined the proportion of eligible men (ie, men aged 18-21 years) who reported receiving HPV vaccination.
We separated alcohol consumption into a 2-level variable: low risk for developing an alcohol use disorder vs high risk for developing an alcohol use disorder. Low-risk drinking was defined as consuming 0-14 drinks per week or ≤4 drinks per day, and high-risk drinking was defined as consuming >14 drinks per week or >4 drinks per day, as defined by the National Institute on Alcohol Abuse and Alcoholism [23] .
Smoking status was categorized as never smoker, current smoker, and former smoker.
Sexual behavior information (eg, age of first sexual encounter, lifetime number of sexual partners, condom use) was collected using an audio computer-assisted self-interview. In addition, participants were asked about the history of other infections (eg, herpes/genital warts) and circumcision status.
Statistical Analysis
The high-risk category included HPV subtypes 16, 18, 26, 31, 33, . Non-Hispanic blacks (65.0%) had the highest prevalence of any HPV infection, followed by Hispanics (44.4%) and non-Hispanic whites (43.7%). Penile HPV was more common among men who were widowed, separated, or divorced (63.7%) than among men who were never married (48.7%) or who were married and/or living with a partner (42.5%). HPV prevalence was significantly higher among high-risk drinkers (55.9%) compared with low-risk drinkers (44.4%). The overall HPV prevalence was higher among current smokers (60.6%), followed by former smokers (50.9%) and never smokers (36.2%).
There were no significant differences in penile HPV prevalence by family poverty level or hepatitis B diagnosis. Finally, there was no difference in prevalence by receipt of HPV vaccine. We did not report prevalence of quadrivalent HPV types (ie, types 6, 11, 16, and 18) by receipt of HPV vaccine, as a relative standard error to evaluate this association was ≥30%; however, we found that only 20.8% of men who were eligible to receive HPV vaccine reported receiving it (data not shown). Figure 1 illustrates the prevalence of any HPV infection by condom use and lifetime number of sexual partners. The prevalence was highest (almost 80%) among intermittent condom users who reported having 6-15 lifetime sex partners.
Type-Specific Prevalence of HPV Infection
Type-specific high-risk and low-risk HPV prevalence is presented in Figure 2A and 2B. The top 5 high-risk HPV types were types 51 (5.5%), 53 (5.4%), 16 (4.3%), 66 (4.2%), and 59 (3.8%). The top 5 low-risk HPV types were 62 (7.5%), 84 (6.8%), 89 (5.5%), 61 (4.6%), and 54 (68%).
DISCUSSION
Ours is the first nationally representative population-based study estimating the prevalence of penile HPV infection in the United States. The prevalence of any penile HPV infection was 45.2% among men aged 18-59 years. Furthermore, 30.5% of all men were infected with high-risk HPV types. This approximates to 34.8 million US men infected with penile HPV infection and nearly 23.4 million infected with high-risk HPV.
Unlike cervical, oral, and anal HPV infections where prevalence by age follows lognormal, bimodal, and horizontal linear patterns, respectively [5, 8, 9] , penile HPV infection seems to be following an upward linear pattern in which incidence increases consistently with increase in age, with the highest prevalence observed among 55-to 59-year-old men. A possible explanation for higher prevalence among older men might be explained by increased latent penile HPV infection due to age-related loss of immunity or increased persistent or slower clearance of infection among older men [24] .
Prevalence of high-risk HPV infection among men who reported ever performing oral or anal sex with women or men was almost 1.5-to 2-fold higher than the prevalence among men who reported never performing oral or anal sex with women or men. Furthermore, the prevalence increases with increase in number of lifetime sex partners. Taken together, these trends indicate the strength of association between penile HPV and sexual activity. Next, we estimated prevalence by condom use and found that the prevalence was highest among men who reported using condoms intermittently. It is interesting to note that the prevalence was similar among men who reported never using condoms and men who reported always using condoms during the past 12 months. Upon further assessment of whether the prevalence of any HPV varies by condom use and number of sexual partners, we found that the prevalence of any HPV infection was highest (80%) among those men who had reported using condoms intermittently and had ≥16 lifetime sexual partners; this is higher than among men who reported always using condoms and having ≥16 lifetime sexual partners. Further research is needed to investigate this trend.
The prevalence was higher for other modifiable risk factors including high-risk drinking and smoking. Previous studies found a strong association between cigarette smoking and increased risk of penile cancer. However, the role that smoking plays in the development of penile HPV infection or penile cancer remains unknown [25] [26] [27] . One potential mechanism for this association can be explained by the fact that tobacco may exert its action through its metabolites or directly after systemic absorption, increasing the risk of penile HPV infection [26, 28] .
Finally, we investigated the prevalence of penile HPV infection among circumcised vs uncircumcised men. Contrary to the existing literature [29] , we found that the prevalence of any and high-risk HPV was slightly higher in men who were circumcised, compared with men who were uncircumcised. A possible explanation for this higher prevalence in circumcised men might be that childhood circumcision is known to [30] . There might be a similar association between penile HPV infection and age of circumcision. Because NHANES does not collect data on age at circumcision, the observed association in our study should be interpreted within the context of this limitation.
Due to insufficient information, the efficacy of HPV vaccination for penile precancerous lesions and penile cancer prevention was not understood [31, 32] . Thus, there is no recommendation for the use of HPV vaccine for prevention of penile precancerous lesions and penile cancer [31] . Although no significant relationship was demonstrated, we found that men who reported receiving HPV vaccine had slightly lower prevalence of any and high-risk HPV infection; the prevalence of low-risk HPV infection among men who reported receiving vaccine was almost half. The uptake of HPV vaccine among these men was low: only 20.8% of those who were eligible (18-21 years of age) reported receiving HPV vaccine. This uptake rate approximates to the national HPV vaccine uptake rate of 21% among boys and young men [33] . When we estimated the uptake among 18-to 26-year-old men (of whom 22-to 26-yearold men were eligible permissively), the uptake rate dropped further to 14.8%.
Our study has several limitations. First, the measures of risky behaviors are self-reported. Some behaviors, specifically sexual behaviors, are likely to be underreported due to social desirability bias and recall bias. However, self-report is the only way to obtain these data and is a standard practice. Second, self-collected penile swab samples may not be as accurate as those collected by health providers. Although self-collected penile swab samples may have contamination from other body regions, self-collected penile swabs have been shown to be a reliable method for HPV testing [34] .
In conclusion, the prevalence of penile HPV among US men is substantial. Penile HPV prevalence increases with increasing age. Risky sexual behavior, smoking, high-risk drinking, and history of herpes or genital warts are risk factors for penile HPV infection.
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